関連文献

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.

Am J Physiol Renal Physiol. 308(2): F114-121, 2014.PubMed

Early prediction of acute kidney injury biomarkers after endovascular stent graft repair of aortic aneurysm: a prospective observational study.

J Intensive Care. 2(45), 2014.PubMed

Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 20(12): 2010-2014, 2014.PubMed

A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.

J Infect Chemother. 21(3): 165-169, 2014.PubMed

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Kidney Int. 87(3): 640-648, 2014.PubMed

Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.

Nephrol Dial Transplant. 29(1): 73-80, 2014.PubMed

Urinary biomarkers and progression of AKI in patients with cirrhosis.

Clin J Am Soc Nephrol. 9(11): 1857-1867, 2014.PubMed

Biomarkers of acute kidney injury in pediatric cardiac surgery.

Clin Biochem. 46(13-14): 1244-1251, 2013.PubMed

Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Am J Kidney Dis. 61(3): 430-439, 2013.PubMed

Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Clin J Am Soc Nephrol. 8(7): 1079-1088, 2013.PubMed